Live Breaking News & Updates on Achille Severgnini
Stay updated with breaking news from Achille severgnini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brothers make billions from ex-merger banker's pharma firm moneyweb.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneyweb.co.za Daily Mail and Mail on Sunday newspapers.
(Bloomberg) Germano and Giammaria Giuliani’s family made a fortune with remedies for hair loss, indigestion and sensitive skin. The family business is still making money after more than a century in operation, but what’s really driving the brothers’ wealth is a bet on another health-care company.The Giulianis hold stakes worth about $3 billion in Royalty Pharma Plc, a New York-based firm that buys pharmaceutical royalties from academic institutions, research hospitals and drugmakers such as Pfizer Inc. Its shares have surged 70% since an initial public offering last year. The Giulianis first invested in Royalty Pharma after Germano and his father met founder Pablo Legorreta in an airport in Milan in 1996, the same year the former Wall Street banker set up the company. They parlayed proceeds from their closely held family business Giuliani Spa into an early fundraising round for Royalty Pharma and added more ahead of its IPO. Their investment has returned at least 250% in th ....
Brothers Make Billions From Ex-Merger Bankerâs Pharma Firm This content was published on February 17, 2021 - 12:11 February 17, 2021 - 12:11 (Bloomberg) Germano and Giammaria Giulianiâs family made a fortune with remedies for hair loss, indigestion and sensitive skin. The family business is still making money after more than a century in operation, but whatâs really driving the brothersâ wealth is a bet on another health-care company.The Giulianis hold stakes worth about $3 billion in Royalty Pharma Plc, a New York-based firm that buys pharmaceutical royalties from academic institutions, research hospitals and drugmakers such as Pfizer Inc. Its shares have surged 70% since an initial public offering last year. ....